These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25675976)

  • 61. Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study.
    Trottier H; Mayrand MH; Coutlée F; Monnier P; Laporte L; Niyibizi J; Carceller AM; Fraser WD; Brassard P; Lacroix J; Francoeur D; Bédard MJ; Girard I; Audibert F
    Papillomavirus Res; 2016 Dec; 2():145-152. PubMed ID: 29074173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes.
    Beerens E; Van Renterghem L; Praet M; Sturtewagen Y; Weyers S; Temmerman M; Depypere H; Claeys P; Cuvelier CA
    Cytopathology; 2005 Aug; 16(4):199-205. PubMed ID: 16048506
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    Ebisch RMF; Rutten DWE; IntHout J; Melchers WJG; Massuger LFAG; Bulten J; Bekkers RLM; Siebers AG
    J Clin Oncol; 2017 Aug; 35(22):2542-2550. PubMed ID: 28541790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution.
    Tanaka Y; Ueda Y; Kakuda M; Kubota S; Matsuzaki S; Nakagawa S; Egawa-Takata T; Matsuzaki S; Kobayashi E; Yoshino K; Kimura T
    Int J Clin Oncol; 2016 Aug; 21(4):730-734. PubMed ID: 26694812
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence of cervical intraepithelial lesions and human papilloma virus infection in female renal transplant recipients.
    Parra-Avila I; Jiménez-Santana ML; Barrón-Sánchez RE; Martínez-Gamboa RA; Alberú J; Morales-Buenrostro LE; Cravioto MD
    Transpl Infect Dis; 2021 Aug; 23(4):e13622. PubMed ID: 33877726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.
    Gravitt PE; van Doorn LJ; Quint W; Schiffman M; Hildesheim A; Glass AG; Rush BB; Hellman J; Sherman ME; Burk RD; Wang SS
    J Clin Microbiol; 2007 Oct; 45(10):3245-50. PubMed ID: 17699644
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
    Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
    Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human papillomavirus: often harmless but in some cases carcinogenic.
    Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.
    Lopez-Cavanillas B; G Benitez C; Serrano M; Sendagorta E; Hernandez A; Bartha JL
    J Obstet Gynaecol; 2021 Oct; 41(7):1139-1144. PubMed ID: 33459109
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Investigating a cluster of vulvar cancer in young women: a cross-sectional study of genital human papillomavirus prevalence.
    Rumbold AR; Tan SE; Condon JR; Taylor-Thomson D; Nickels M; Tabrizi SN; Davy ML; O'Brien MM; Connors CM; Zardawi I; Stankovich J; Garland SM
    BMC Infect Dis; 2012 Oct; 12():243. PubMed ID: 23040203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human papillomavirus detection by hybrid capture in paired cervicovaginal lavage and cervical biopsy specimens.
    Brown DR; Rawlings K; Handy V; Fife KH; Bryan JT; Cramer H; Graham M
    J Med Virol; 1996 Feb; 48(2):210-4. PubMed ID: 8835357
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study.
    Origoni M; Stefani C; Dell'Antonio G; Carminati G; Parma M; Candiani M
    J Clin Virol; 2011 Aug; 51(4):250-4. PubMed ID: 21680237
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comparison of cervical and vaginal human papillomavirus.
    Castle PE; Rodriguez AC; Porras C; Herrero R; Schiffman M; Gonzalez P; Hildesheim A; Burk RD
    Sex Transm Dis; 2007 Nov; 34(11):849-55. PubMed ID: 17621246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico.
    Flores-Miramontes MG; Torres-Reyes LA; Alvarado-Ruíz L; Romero-Martínez SA; Ramírez-Rodríguez V; Balderas-Peña LM; Vallejo-Ruíz V; Piña-Sánchez P; Cortés-Gutiérrez EI; Jave-Suárez LF; Aguilar-Lemarroy A
    Virol J; 2015 Oct; 12():161. PubMed ID: 26444975
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative performance of human papillomavirus DNA testing using novel sample collection methods.
    Gage JC; Partridge EE; Rausa A; Gravitt PE; Wacholder S; Schiffman M; Scarinci I; Castle PE
    J Clin Microbiol; 2011 Dec; 49(12):4185-9. PubMed ID: 21998422
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human papillomavirus-related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence.
    Nailescu C; Ermel AC; Shew ML
    Pediatr Transplant; 2022 Nov; 26(7):e14341. PubMed ID: 35808949
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
    Siddiqa A; Zainab M; Qadri I; Bhatti MF; Parish JL
    Viruses; 2014 Jul; 6(7):2762-77. PubMed ID: 25036463
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cervicovaginal secretions protect from human papillomavirus infection: effects of vaginal douching.
    Chu TY; Chang YC; Ding DC
    Taiwan J Obstet Gynecol; 2013 Jun; 52(2):241-5. PubMed ID: 23915858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.